Becton Dickinson invests $50m in Columbus expansion:
This article was originally published in Clinica
Executive Summary
Becton Dickinson is to inject $50m into its Columbus, Ohio operations, adding two new manufacturing lines for prefilled syringes in response to growing demand BD told Clinica. The expansion, which also includes a new sterilisation building, will create 75 new jobs over the next 18 months. The company expects to complete one production line by early 2005 and the second in 2006.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.